ArticleInternational journal of molecular medicine2023

HER3/Akt/mTOR pathway is a key therapeutic target for the reduction of triple‑negative breast cancer metastasis via the inhibition of CXCR4 expression.

Tomoya Takeda et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.